For research use only. We do not sell to patients.
IHCH-3064
CAS No. : 2420562-65-6
Biological Activity：IHCH-3064 is a dual-acting compounds targeting Adenosine A2A Receptor and HDAC. IHCH-3064 exhibits potent binding to A2AR (Ki=2.2 nM) and selective inhibition of HDAC1 (IC50=80.2 nM), with good antiproliferative activity against tumor cell lines in vitro. IHCH-3064 is a tumor immunotherapeutic agent.
Research Area：Cancer|Inflammation/Immunology
Targets：HDAC|Adenosine Receptor
Related Small Molecules:Pivanex;Crotonoside;MRS 1523;MPT0B390;APNEA;RSC133;MIPS521;HDAC1/6-IN-1;HDAC/HSP90-IN-4;Derenofylline;JPS014;FSCPX;HDAC-IN-4;Theobromine-d3;HDAC-IN-27;1-Alaninechlamydocin;SKLB-23bb;Tacedinaline;Inosine-13C;Norisoboldine;N-0861 racemate;HPOB;HDAC-IN-28;CG347B;Tubacin;HDAC10-IN-1;HDAC6-IN-6
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
